Fingerprint
Dive into the research topics of 'FOLFIRINOX versus gemcitabine-based therapy for pancreatic ductal adenocarcinoma: Lessons from patient-derived cell lines'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
FOLFIRINOX versus gemcitabine-based therapy for pancreatic ductal adenocarcinoma: Lessons from patient-derived cell lines
Sebastian K.S. Begg, David J. Birnbaum, Jeffrey W. Clark, Mari Mino-Kenudson, Ulrich F. Wellner, Oliver Schilling, Keith D. Lillemoe, Andrew L. Warshaw, Carlos Fernández Del Castillo, Andrew S. Liss*
*Corresponding author for this work